PP
CELL

Paloma Partners’s PhenomeX Inc. Common Stock CELL Stock Holding History

Paloma Partners’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-45,473
Closed -$323K – 1899
2022
Q1 		$323K Sell
45,473
-6,135
-12% -$50.7K 0.01% 1096
2021
Q4 		$938K Buy
+51,608
New +$1.11M 0.01% 753

Other funds holding CELL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paloma Partners's CELL Position: Q2 2022 in Review

Paloma Partners sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2022, closing a stake of 45,473 shares — an estimated $323K sold.

Paloma Partners first reported a position in CELL in Q4 2021 and held it in 2 quarters. The position peaked at $938K in Q4 2021. 123 funds tracked by Wall St. Rank hold CELL as of Q2 2022.

  • Paloma Partners reported no remaining PhenomeX Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Paloma Partners sold 45,473 PhenomeX Inc. Common Stock shares in Q2 2022, an estimated $323K.
  • Paloma Partners first reported a position in PhenomeX Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Paloma Partners's PhenomeX Inc. Common Stock position peaked at $938K in Q4 2021.
  • 123 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2022.

Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.